Complications Associated With Ureteroscopic Management of Upper Tract Urothelial Carcinoma

被引:17
作者
Linehan, Jennifer [1 ]
Schoenberg, Mark [2 ,3 ]
Seltzer, Elyse [4 ]
Thacker, Kim [4 ]
Smith, Angela B. [5 ]
机构
[1] John Wayne Canc Inst, Dept Urol, Providence St Johns Hlth Ctr, Santa Monica, CA USA
[2] Montefiore Med Ctr, Dept Urol, Bronx, NY USA
[3] Albert Einstein Coll Med, Bronx, NY USA
[4] UroGen Pharma, New York, NY USA
[5] Univ N Carolina, Dept Urol, Lineberger Comprehens Canc Ctr, 101 Manning Dr, Chapel Hill, NC 27541 USA
关键词
UPPER URINARY-TRACT; TRANSITIONAL-CELL CARCINOMA; GUERIN PERFUSION THERAPY; BACILLE CALMETTE-GUERIN; TERM-FOLLOW-UP; ENDOSCOPIC TREATMENT; RADICAL NEPHROURETERECTOMY; PERCUTANEOUS MANAGEMENT; IN-SITU; ENDOUROLOGICAL MANAGEMENT;
D O I
10.1016/j.urology.2020.09.036
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES To compile and examine safety data from clinical studies of endoscopic management of patients with low-grade upper tract urothelial carcinoma (UTUC) to identify rates and factors associated with reported complications. METHODS Ovid Medline and Ovid Medline Daily (with Embase as secondary search) including citations from 1946-2018 were queried using the following terms: ureteroscopy, ureter, catheter, endoscopy, complication, adverse events, morbidity, ablation, laser, upper tract urothelial carcinoma, ureteral stricture, ureteral stenosis, and ureteral injury. Abstracts were reviewed for relevance; diagnostic studies, case studies, and reviews were excluded. RESULTS Thirty-eight publications (7 prospective, 31 retrospective) representing >1100 patients were identified. Ureteral stricture was the most frequently reported complication (studies; rates) (26/38; 0-27%), with incidence associated with number of procedures and treatment method. Bleeding, infection, and fever were most common with adjuvant treatment (BCG or mitomycin). Serious and fatal complications were rare. CONCLUSIONS Ureteral stricture is the most frequent complication of endoscopic UTUC management but can be managed successfully in most cases. Most complications were minor. Although additional prospective studies are needed, these results support the safety of ureteroscopic management of UTUC in appropriately selected patients. (C) 2020 Elsevier Inc.
引用
收藏
页码:87 / 95
页数:9
相关论文
共 50 条
  • [31] Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of low-risk upper tract urothelial carcinoma
    Mandalapu, Rao S.
    Remzi, Mesut
    de Reijke, Theo M.
    Margulis, Vitaly
    Palou, J.
    Kapoor, A.
    Yossepowitch, Ofer
    Coleman, Jonathan
    Traxer, Olivier
    Anderson, J. Kyle
    Catto, James
    de la Rosette, Jean
    O'Brien, Timothy
    Zlotta, Anthony
    Matin, Surena F.
    WORLD JOURNAL OF UROLOGY, 2017, 35 (03) : 355 - 365
  • [32] A Case for Nephron Sparing Surgery in the Management of Upper Tract Urothelial Carcinoma
    Motamedinia, Piruz
    Hoenig, David
    Okeke, Zeph
    Smith, Arthur
    JOURNAL OF ENDOUROLOGY, 2016, 30 : S18 - S22
  • [33] Future strategies to enhance kidney preservation in upper urinary tract urothelial carcinoma
    Metcalf, Meredith
    Pierorazio, Phillip M.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2020, 9 (04) : 1831 - 1840
  • [34] Nephron-sparing approaches in the management of upper tract urothelial carcinoma: indications and clinical outcomes
    Ko, Young Hwii
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (10) : 6589 - 6595
  • [35] Improving management of upper tract urothelial carcinoma
    Tay, Li June
    Chatterton, Kathryn
    Colemeadow, Josie
    Nair, Rajesh
    Bultitude, Matthew
    Thomas, Kay
    BJU INTERNATIONAL, 2020, 126 (01) : 5 - 6
  • [36] Genomic Characterization of Upper Tract Urothelial Carcinoma
    Sfakianos, John P.
    Cha, Eugene K.
    Iyer, Gopa
    Scott, Sasinya N.
    Zabor, Emily C.
    Shah, Ronak H.
    Ren, Qinghu
    Bagrodia, Aditya
    Kim, Philip H.
    Hakimi, A. Ari
    Ostrovnaya, Irina
    Ramirez, Ricardo
    Hanrahan, Aphrothiti J.
    Desai, Neil B.
    Sun, Arony
    Pinciroli, Patrizia
    Rosenberg, Jonathan E.
    Dalbagni, Guido
    Schultz, Nikolaus
    Bajorin, Dean F.
    Reuter, Victor E.
    Berger, Michael F.
    Bochner, Bernard H.
    Al-Ahmadie, Hikmat A.
    Solit, David B.
    Coleman, Jonathan A.
    EUROPEAN UROLOGY, 2015, 68 (06) : 970 - 977
  • [37] Prognostic factors of upper tract urothelial carcinoma
    Elalouf, V.
    Klap, J.
    Delongcharnps, N. -B.
    Conquy, S.
    Sibony, M.
    Saighi, D.
    Peyromaure, M.
    Flam, T.
    Zerbib, M.
    Xylinas, E.
    PROGRES EN UROLOGIE, 2013, 23 (16): : 1382 - 1388
  • [38] Optimizing management of upper tract urothelial carcinoma
    Campbell, Matthew T.
    Shah, Amishi Y.
    Matin, Surena F.
    Siefker-Radtke, Arlene O.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (07) : 492 - 498
  • [39] Inadequacy of Biopsy for Diagnosis of Upper Tract Urothelial Carcinoma: Implications for Conservative Management
    Smith, Armine K.
    Stephenson, Andrew J.
    Lane, Brian R.
    Larson, Benjamin T.
    Thomas, Anil A.
    Gong, Michael C.
    Jones, J. Stephen
    Campbell, Steven C.
    Hansel, Donna E.
    UROLOGY, 2011, 78 (01) : 82 - 86
  • [40] Treatment Patterns, Outcomes, and Costs Associated With Localized Upper Tract Urothelial Carcinoma
    Fero, Katherine E.
    Shan, Yong
    Lec, Patrick M.
    Sharma, Vidit
    Srinivasan, Aditya
    Movva, Giri
    Baillargeon, Jacques
    Chamie, Karim
    Williams, Stephen B.
    JNCI CANCER SPECTRUM, 2021, 5 (06)